Co-Diagnostics Inc (HAM:C970)

Q3 2025 Co-Diagnostics Inc Earnings Call Transcript

Nov 13, 2025 / 09:30 PM GMT

Release Date Price: €9.54 (-1.85%)

Transcript 10-Q8-K

Key Points

Positve

Co-Diagnostics Inc (CODX) announced a strategic engagement with Maxim Group to explore potential strategic alternatives for its Indian joint venture, Cosera Diagnostics, which could unlock significant value.
The company has formed a new joint venture, Cora Diagnostics, with Arabian Eagle Manufacturing, expanding its presence in Saudi Arabia and 18 additional MENA nations.
Co-Diagnostics Inc (CODX) is advancing its AI business unit to drive innovation and operational efficiency, enhancing its data-driven opportunities.
The company is initiating clinical evaluations for its upper respiratory multiplex test, which is designed to detect flu A, flu B, COVID-19, and RSV simultaneously, highlighting its scientific leadership.
Co-Diagnostics Inc (CODX) has closed two strategic direct offerings, raising gross proceeds of $10.8 million, strengthening its financial position.

Negative

Total revenue for Q3 2025 was $0.1 million, a significant decrease from $0.6 million in the same period last year.
The company reported a net loss of $5.9 million for Q3 2025, although this was an improvement from the $9.7 million loss in the same period last year.
Revenue from grants, which was $0.4 million in the prior year period, was absent in Q3 2025, with all revenue coming from product sales.
Despite progress, the commercialization of the new platform and other initiatives are still in the preparatory stages, with significant milestones expected in 2026.
The company is still in the process of evaluating financing structures to strengthen its financial position, indicating ongoing financial challenges.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CODX.OQ - Co-Diagnostics Inc
Q3 2025 Co-Diagnostics Inc Earnings Call
Nov 13, 2025 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hello and thank you for standing by. My name is Tiffany and I will be your conference operator today. At this time, I would like to welcome everyone to the Co Diagnostics Inc. 3rd quarter 2025 earnings webcast.

All lines have been placed on mute to prevent any background noise.

After the speaker's remarks, there will be a question-and-answer session. If you would like to ask a question during that time, simply press star, then the number one on your telephone keypad.

I would now like to turn the call over to Andrew Benson, head of investor relations. Andrew, please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.